RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Risks and Rewards

In Focus: Risks and Rewards

Posted 01 September 2011

The September issue of Regulatory Focus considers various systems used to assess and manage the risks and potential hazards associated with developing medical products. Monitoring risk is an essential component in both the medical device and drug development arenas. Medical device and pharmaceutical companies need to have appropriate programs in place to evaluate potential risks associated with their products as well as mechanisms (e.g., inquiries, complaints, market studies, focus groups, servicing) to capture customer feedback regarding product use.


© 2022 Regulatory Affairs Professionals Society.